Incidence of and Risk Factors for Infectious Complications After Intensified Immunosuppressive Therapy for Kidney Allograft Rejection at a Tertiary Referral Center in Mexico City (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO1121; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Treatment intensity was classified as mild (corticosteroids alone), moderate (corticosteroids plus one additional therapy), and high (corticosteroids, plasma exchange, Intravenous Immunoglobulin, and Rituximab, with or without Bortezomib or Daratumumab). Conclusion More than half of kidney transplant recipients developed clinically significant infections within 180 days after intensified treatment for allograft rejection. Greater treatment intensity, baseline lymphopenia, and prior rejection episodes were independently associated with infection and may help identify patients who require closer infectious surveillance"
Clinical • Antibody-mediated Rejection • Cytomegalovirus Infection • Infectious Disease • Nephrology • Pneumonia • Respiratory Diseases • Transplant Rejection • Tuberculosis
|
|
Jesus Ivan Santander; Luis Eduardo Morales Buenrostro
|